Developer of genome-scale sequencing technology designed to offer analytical services to enterprises.
Biotechnology📍 Fremont, CAFounded 2016
Current Valuation
$3.6B
as of 2022-Q2
UNICORN
Developer of genome-scale sequencing technology designed to offer analytical services to enterprises.
Company Profile
Founded
2016
HQ
Fremont, CA
Employees
304
Total Raised
$600M
Last Round
Series E — $229.25M (May 2022)
IPO Status
private
Fundraising Status
Series E · $229.25M · 4y 3mo ago
privateTotal raised $600M
Secondary Market
Implied price / share
$24.96
Last round price / share
$50.14
vs last round
-50.2%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series E
$229.25M
May 2022
—
$3.6B
MedicalHealth CareBiotechnologyLife Science
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q2. Refreshed quarterly.